Similar efficacy of thalidomide- and bortezomib-based regimens for first relapse of multiple myeloma.
Krejci M, Gregora E, Straub J, Minarik J, Scudla V, Adam Z, Krivanova A, Pour L, Zahradova L, Buchler T, Mayer J, Hajek R.
Krejci M, et al. Among authors: krivanova a.
Ann Hematol. 2011 Dec;90(12):1441-7. doi: 10.1007/s00277-011-1206-3. Epub 2011 Mar 5.
Ann Hematol. 2011.
PMID: 21380511